News

4Kscore featured on UroToday: AUA 2017

AUA 2017 just wrapped up in Boston, MA. On Sunday May, 14, Dr. Karim Marzouk and colleagues from Memorial Sloan Kettering Cancer Center presented a poster titled “Combining 4Kscore and MRI for Prostate Biopsy Decision Making”. The session highlighted the findings from the recently published PROMIS MRI trial, utilizing the multiparameteric MRI (mpMRI) as a […]

Press Release

OPKO Health’s 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting

Prospective study conducted at Veteran Affairs hospitals confirms 4Kscore accurately predicts aggressive prostate cancer MIAMI, May 18, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive prostate cancer were presented in a podium presentation […]

Press Release

OPKO Announces Multiple Presentations at the 112th American Urological Association Annual Meeting

Highlights 4Kscore’s ability to predict aggressive prostate cancer Showcasing 4Kscore and Claros 1 Point-of-Care System at Exhibit Booth #904 MIAMI, May 15, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq:OPK) announces that multiple podium and poster presentations highlighting the Company’s 4Kscore test will be presented at the 112th American Urological Association (AUA) Annual Meeting taking […]

blog

We Hope to See You at AUA2017!

The American Urological Association’s 2017 Annual Meeting is just around the corner. This annual event provides the ideal platform for thought leaders in the field to explore the latest advances in urologic medicine. Attendees from around the globe will gather in Boston, Massachusetts, May 12 – 16, for the 112th AUA Annual Meeting. Last year’s […]

blog

Why the 4Kscore is Important to Physicians and Patients

Nearly 3 million men live with prostate cancer in the US, with more than 160,000 new cases diagnosed each year[1].  Prostate cancer remains the second leading cause of cancer death in men[2], which is why it’s important to find aggressive prostate cancers early when treatment can still be effective.  Unfortunately, current methods for screening and […]

blog

4Kscore Test: A Clinically Proven Prostate Cancer Test

The 4Kscore accurately provides the risk of aggressive prostate cancer, reducing the number of unnecessary prostate biopsies performed annually. The accuracy of the 4Kscore algorithm to provide the risk of high grade prostate cancer is based on over a decade of research completed by scientists at Memorial Sloan Kettering Cancer Center and other leading international […]